Showing 1331-1340 of 1648 results for "".
- Allergan Aesthetics Celebrates 100 Million Syringes of JUVÉDERMhttps://modernaesthetics.com/news/allergan-aesthetics-celebrates-100-million-syringes-of-juvederm/2473294/Drumroll, please…Allergan Aesthetics, an AbbVie company, has produced and shipped 100 million syringes of JUVÉDERM products globally. Since its launch in 2000, the JUVÉDERM Collection of Fillers has grown to where its products are now available in mo
- Physician Growth Partners Advises on Women's Health Partnership in Chicagohttps://modernaesthetics.com/news/physician-growth-partners-advises-on-womens-health-partnership-in-chicago/2473293/Through a new partnership, Together Women’s Health, a portfolio company of Shore Capital Partners, has entered into the Chicago market and will empower The Northwestern Specialists for Women with significant resources to continue its growth.
- FDA Grants 510(k)Clearance to LASEROPTEK's HELIOS IV-785 for Aesthetic and Medical Dermatology Usehttps://modernaesthetics.com/news/fda-grants-510kclearance-to-laseropteks-helios-iv-785-for-aesthetic-and-medical-dermatology-use/2473291/The U.S. Food and Drug Administration has granted 510(k) clearance to LASEROPTEK Co., Ltd.’s HELIOS IV-785 laser system for aesthetic and medical dermatology applications. HELIOS IV-785's novel and synergistic combination of 785nm picosecond photoacoustic effect and 1064 &
- FDA Approves Avéli for Long-Term Reduction of Cellulite In the Buttocks and Thighshttps://modernaesthetics.com/news/fda-approves-reveli-for-long-term-reduction-of-cellulite-in-the-buttocks-and-thighs/2473290/Revelle Aesthetics, Inc. scored an extended FDA clearance for Avéli. Avéli is now indicated for long-term reduction in the appearance of cellulite in the buttocks and thigh areas of adult females, demonstrating benefits through one year. "For far too l
- Revision Skincare, RVL Pharmaceuticals Form Partnershiphttps://modernaesthetics.com/news/revision-skincare-rvl-pharmaceuticals-form-partnership/2473288/Revision Skincare® is partnering with RVL Pharmaceuticals, Inc. the owner of UPNEEQ®, to collaborate on a variety of marketing efforts within the medical aesthetics industry, working together to address significant unmet consumer needs. Revisions says that, with shared
- Allergan Aesthetics Announces Double Allē Points Promotion for Juvederm Usershttps://modernaesthetics.com/news/allergan-aesthetics-announces-double-alle-points-promotion-for-juvederm-users/2473281/Consumers can earn double points in Allē, Allergan Aesthetics' loyalty rewards program, when treated with two or three syringes from the JUVÉDERM Collection of Fillers during the same visit. Allē points can be redeemed for future Allē-eligible treatments or products.&nb
- New from Senté: Cysteamine HSA Pigment & Tone Correctorhttps://modernaesthetics.com/news/new-from-sente-cysteamine-hsa-pigment-tone-corrector/2473279/Cysteamine HSA Pigment & Tone Corrector from Senté has launched to safely and effectively target pigmentation in all skin tones. The hydroquinone-free formula is safe for long-term use and formulated for all skin types, including dry or sensitive skin. Cystea
- Alma Rolls Out Alma Hybrid and Alma TED Systems in Canadahttps://modernaesthetics.com/news/alma-rolls-out-alma-hybrid-and-alma-ted-systems-in-canada/2473278/Alma Hybrid and Alma TED systems are now commercially available in Canada, the company reports. Alma Hybrid, the first laser platform to include an ablative 10,600 nm (CO2) laser and a non-ablative 1570 nm laser for skin resurfacing that offers a comprehensive solution to utilize each b
- Aesthetics Biomedical Inc. Scores Third U.S. Patent for SoME Skincarehttps://modernaesthetics.com/news/aesthetics-biomedical-inc-scores-third-us-patent-for-some-skincare/2473277/Aesthetics Biomedical Inc. scored its third U.S. patent for “biological preserving composition and methods of use” for its SoME skincare product line. The patent covers topical compositions for combining biologics with skincare preserving the exclusivity of SoME Skincar
- JUVÉDERM VOLUX XC Scores FDA Nod for Jawline Definitionhttps://modernaesthetics.com/news/juvederm-volux-xc-scores-fda-nod-for-jawline-definition/2473275/The U.S. FDA has given its nod to JUVÉDERM VOLUX XC for the improvement of jawline definition in adults over the age of 21 with moderate to severe loss of jawline definition. "The approval of JUVÉDERM VOLUX XC represents the largest leap in innova